Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
   
 
                                                                                                
      
 

Resident Seminar - March 14, 2019


 
 
DOWNLOAD A SCHEDULE » DOWNLOAD EVALUATION TEMPLATE » CE INSTRUCTIONS » REQUEST PARKING » MAP & DIRECTIONS »
**PARKING IS AT CAPACITY. No additional requests can be accommodated. We apologize for the inconvenience.**
 
 
 
March 2019 Resident Seminar
St. Louis College of Pharmacy
 
 
 
SCHEDULE:
 
 
These Resident Seminar sessions are those that were rescheduled from January 11, 2019 as a result of the snow storm.
 
 
 
ARB 304
ARB 305
ARB 336
Block 1
1:00 – 1:45 PM
The management of opioid withdrawal and detoxification in an inpatient setting
 
Arianne MacGillivray, Pharm.D.
SSM Health DePaul Hospital
Place in therapy of PCSK9 Inhibitors for Cholesterol Management
 
Tammy Nguyen, Pharm.D.
St. Luke’s Hospital
Increased Risk of Death with Pimavanserin
 
Christine Heath, Pharm.D.
VA St. Louis Health Care System/St. Louis College of Pharmacy
Break
Block 2
1:55 – 2:40 PM
Medical marijuana for chronic non-cancer pain
 
Taylor Kirby, Pharm.D.
VA St. Louis Health Care System/St. Louis College of Pharmacy
Appropriate Antithrombotic Therapy in Patients with Coronary Artery Disease and Atrial Fibrillation
 
Alex Meyr, Pharm.D.
SSM Health St. Mary’s Hospital
INSTIgratification: the Future of HIV Treatment with Long-Acting, a Review of Cabotegravir
 
Shelby Allen, Pharm.D.
St. Louis College of Pharmacy/Schnucks
 
** Up to 0.75 hours of CE credit are available for each activity, for a maximum possible 1.5 hours if participants attend activities in both time blocks.**
 
 
 
 
 
DOWNLOAD A SCHEDULE » DOWNLOAD EVALUATION TEMPLATE » CE INSTRUCTIONS » REQUEST PARKING » MAP & DIRECTIONS »
**PARKING IS AT CAPACITY. No additional requests can be accommodated. We apologize for the inconvenience.**
 
 

 
REGISTRATION & PARKING INFORMATION
**PARKING IS AT CAPACITY. No additional requests can be accommodated. We apologize for the inconvenience.** This event has mutliple concurrent sessions.  To register, click the green button below. You will be asked to log in. You will be registered for the whole day - please complete the evaluations for only those sessions that you attend. Unattended sessions will be removed from your account, based on sign-in records, within a week following Seminar. 
 
Registration is free, but is required in advance. Due to limited space, only those participants who register before 12:00 PM on Monday, March 11, 2019 will be able to request parking access on campus.
 
To request parking, please first register for your desired sessions. Then, complete the parking questionnaire using the link above, or by clicking here », to complete your parking request. If you do not request parking on our campus, or if you do not submit your requst by the deadline, you will be re-directed upon arrival. A temporary parking pass will be emailed to the address you provide in the separate parking request form on the day prior to the event.
 
 
MAP & DIRECTIONS » REQUEST PARKING »
 
 
HANDOUTS
Paper copies of handouts will be provided in each room as well as electronically on this website. Copies of PowerPoint slides are not provided. To access the handouts electronically, participants should ensure they are logged in before accessing this event. Click the + symbol beside the session, which will expand the module. A clickable text link to download the handout as a PDF file will be present.
 
ATTENDANCE
All participants will be required to sign in on the paper sheets, located within each room. Paper sign-in sheets will be reconciled against electronic credit reporting on this website.
 
CPE CREDIT
Participants must claim all CPE credit electronically. Participants may claim no more than one 45-minute session for each time block. Additional instructions can be downloaded above or read below.
 
SPECIAL ACCOMMODATIONS
If you require special accommodations, please let us know. Every effort will be made to make accommodations where necessary.
 

Date: Mar 14, 2019 01:00 PM - 02:40 PM

Location: Academic & Research Building

Fee

$0.00

CE Hours

4.50

Registration closes on Mar 29, 2019 12:00 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To learn more about the specific program information, including universal activity numbers (UAN's) and learning objectives, please expand the modules below. Following successful completion of an evaluation, CE credit will be automatically reported to NABP through the CPE Monitor system, using the NABP ePID numbers and date of birth (MMDD) stored in participants' user profiles. Follow this link to learn more about CPE Monitor and the credit reporting process »  Participants are responsible for ensuring receipt of credit; no credit can be corrected or awarded if more than 60 days have passed from the date of the event or if the home study is expired.
 
It is the policy of St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis, to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty participating in this program are expected to disclose to the program audience any real or apparent conflicts of interest related to the content of the presentation.

Requirements for CE Credit

In order to receive CPE Credit, participants are required to submit an evaluation for each attended session.
  • Evaluations will be housed online at this web address for 14 days, after which time they will be closed.
  • Immediately upon submission of the online evaluation, a report will be automatically generated and submitted to CPE Monitor using the NABP ePID and DOB stored in the participant's account profile.
  • Participants should allow up to 48 hours for the credit to sync with their online NABP e-Profiles. Paper statements of credit are not provided.
  • Only ONE session may be claimed per each time block - if multiple concurrent sessions are claimed, participants forfeit CE credit. All CE claims will be cross-checked against the sign-in sheets.

If you experience difficulty, please contact our office so that we may assist you. We are happy to help!

 
Participants are responsible for ensuring accuracy of credit reporting and receipt of credit. It is recommended that participants log on and reivew the information under "my account" prior to submitting the evaluation. NABP ePID and date of birth must be accurate for credit reporting to occur. Evaluations cannot be reopened after 14 days.
 
Participants are encouraged to check their NABP eProfiles for receipt of credit within one week of submitting their evaluation(s). If a participant notices an error in credit on their NABP e-profile, they are encouraged to contact our office as soon as possible. To best comply with ACPE's CE credit reporting policy, St. Louis College of Pharmacy is unable, for any reason, to award or correct CE credit if more than 60 days have passed from the event.
 
Commercial Support: St. Louis College of Pharmacy reports no external funding in support of this program.
 
 
 

 
** Parking must be requested no later than Monday, March 11, 2019 at 12:00 PM (CST). **
You should not request parking if you already have a STLCOP parking hang tag, plan to carpool and someone else is driving, or have an alternate mode of transportation.
 

 

 

Registration closes on Mar 29, 2019 at 12:00 AM

Registration Closed  

Objectives

  • Identify opioid withdrawal symptoms and the timeline in which these symptoms will most likely occur.
  • Utilize clinical monitoring tools (such as the Clinical Opioid Withdrawal Scale [COWS] or the Subjective Opioid Withdrawal Scale [SOWS]) to make pharmacological treatment recommendations.
  • Evaluate the safety and effectiveness of evidence-based medication-assisted therapies for opioid withdrawal and detoxification in specific patient populations.

Activity Number

0033-0000-18-128-L01-P
Date: 03/14/19
Time: 01:00 PM - 01:45 PM

CE Hours

0.75

Location

ARB 304
Registration Closed  

Registration Closed  

Objectives

  • Identify drug class properties of PCSK9 inhibitors.
  • Recommend an appropriate regimen of PCSK9 inhibitors for cholesterol management.
  • Evaluate guideline recommendations regarding place of therapy for PCSK9 inhibitors.

Activity Number

0033-0000-18-119-L01-P
Date: 03/14/19
Time: 01:00 PM - 01:45 PM

CE Hours

0.75

Location

ARB 305
Registration Closed  

Registration Closed  

Objectives

  • Identify the benefit of pimavanserin??s mechanism of action in Parkinson??s Disease Psychosis.
  • Compare the safety of pimavanserin to other atypical antipsychotics in Parkinson??s Disease Psychosis.

Activity Number

0033-0000-18-125-L01-P
Date: 03/14/19
Time: 01:00 PM - 01:45 PM

CE Hours

0.75

Location

ARB 336
Registration Closed  

Registration Closed  

Objectives

  • Identify patients who are most likely to benefit from the use of medical marijuana for chronic non-cancer pain.
  • Describe drug interactions with marijuana.

Activity Number

0033-0000-18-127-L01-P
Date: 03/14/19
Time: 01:55 PM - 02:40 PM

CE Hours

0.75

Location

ARB 304
Registration Closed  

Registration Closed  

Objectives

  • Identify patients who are candidates to receive dual antiplatelet therapy.
  • Evaluate the safety and efficacy of triple versus dual antithrombotic therapy based on the available literature pertaining to patients with atrial fibrillation and coronary artery disease.
  • Assess the appropriateness of an antithrombotic regimen for a patient with coronary artery disease and atrial fibrillation.

Activity Number

0033-0000-18-129-L01-P
Date: 03/14/19
Time: 01:55 PM - 02:40 PM

CE Hours

0.75

Location

ARB 305
Registration Closed  

Registration Closed  

Objectives

  • Describe the pharmacokinetic profile of cabotegravir.
  • Identify an appropriate dosing regimen based on current studies for the use of long-acting cabotegravir for PrEP therapy.
  • Identify an appropriate dosing regimen based on current studies for the use of long-acting cabotegravir for HIV treatment

Activity Number

0033-0000-18-121-L01-P
Date: 03/14/19
Time: 01:55 PM - 02:40 PM

CE Hours

0.75

Location

ARB 336
Registration Closed